Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL CholesterolZeljko Reiner, Vera A. Bittner, Patricio López‐Jaramillo et al.|Journal of the American College of Cardiology|2021Cited by 143